Mutations in the LRRK2 gene are the most common genetic cause of Parkinson's disease. Giaime et al. show an essential role of LRRK in the survival of dopaminergic neurons and the regulation of the autophagy-lysosomal pathway in the aging brain. Giaime et al., 2017, Neuron 96, 796- 
INTRODUCTION
Parkinson's disease (PD) is the most common neurodegenerative movement disorder characterized neuropathologically by the loss of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc) and the presence of Lewy bodies (LBs) containing a-synuclein (Spillantini et al., 1997) . Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most common genetic cause of PD (Paisá n-Ruíz et al., 2004; Shen, 2004; Zimprich et al., 2004) , but the underlying pathogenic mechanism and the normal physiological role of LRRK2 are unclear. Previous analysis of LRRK2-deficient mice identified no detectable phenotype in the brain but remarkable PD-like changes in the aged kidney, including striking a-synuclein accumulation and aggregation, impairment of protein degradation pathways and increases in apoptosis (Tong et al., , 2012 . These unexpected findings in the kidney are consistent with the report that LRRK2 is normally most abundantly expressed in the kidney (Biskup et al., 2007) .
The pathogenic mechanism underlying LRRK2 mutations is still hotly debated. On the one hand, the most common LRRK2 mutation G2019S, which resides in the kinase domain and causes PD at relatively low penetrance (Bardien et al., 2010; Hulihan et al., 2008; Kachergus et al., 2005; Lesage et al., 2005; Marder et al., 2015) , was reported to increase its autophosphorylation in vitro (Greggio et al., 2006; Nichols et al., 2010; West et al., 2005) . These early findings spurred development of LRRK2 kinase inhibitors as therapies for PD (Atashrazm and Dzamko, 2016) . On the other hand, overexpression of the G2019S and other mutations in LRRK2 even at very high levels (>10-fold) in transgenic mice generally did not lead to DA neurodegeneration (Li et al., 2009 (Li et al., , 2010 Lin et al., 2009; Liu et al., 2015; Melrose et al., 2010; Tsika et al., 2014) . Furthermore, other LRRK2 mutations, such as the R1441C/G/H mutations in the GTPase domain and the Y1699C mutation, did not enhance its kinase activity in vitro (Greggio et al., 2006; Nichols et al., 2010; West et al., 2005) . Thus, it is critically important to elucidate the normal physiological role of LRRK2 in the brain to shed light on the pathogenic mechanism.
We therefore generated LRRK-deficient mice, in which LRRK2 and its functional homolog LRRK1 are inactivated, as LRRK1, which is relatively abundant in the brain (Biskup et al., 2007; Westerlund et al., 2008) , may compensate for the loss of LRRK2 in LRRK2 À/À brains. Unexpectedly, LRRK1/2 double-knockout (LRRK DKO) mice exhibit earlier mortality at $16 months of age with marked reduction of body weight but largely normal brain weight. Interestingly, LRRK DKO mice, but not LRRK1 or LRRK2 single-KO mice, develop age-dependent DA neurodegeneration, as shown by age-dependent reduction of DA neurons in the SNpc at 14-15 months but not at younger ages. The cerebral cortex and cerebellum, however, are unaffected, though noradrenergic neurons in the locus coeruleus and medium spiny neurons of the striatum are also reduced in LRRK DKO mice at 15 months. The selective, age-dependent neurodegeneration is accompanied by increases in apoptotic cell death, increased levels of a-synuclein, and impaired autophagy-lysosomal pathway. Quantitative electron microscopy (EM) analysis further revealed dramatic increases of autophagic vacuoles in the SNpc of LRRK DKO mice at 10 months, before the onset of DA neuron loss and increases of apoptosis. These results demonstrate that LRRK is required for agedependent survival of DA neurons and plays an essential role in the regulation of the autophagy-lysosomal pathway in the aging brain.
RESULTS

Generation and Characterization of LRRK DKO Mice
To generate LRRK-null mice lacking both LRRK1 and LRRK2, we obtained a targeted LRRK1 embryonic stem cell (ESC) clone (EPD0073_6_C01) from the KOMP repository (https://www. komp.org/). The targeted LRRK1 allele contains the gene-trapping En2SA-IRES-lacZ and hbactP-neo selection cassettes in LRRK1 intron 3 and a third loxP site in intron 5 ( Figure 1A ). The entire En2SA-IRES-lacZ and hbactP-neo sequence is flanked (B) Using a downstream cDNA probe specific for LRRK1 exons 25-31 (1,083 bp), northern analysis of poly(A)+ RNA derived from the brain and kidney of heterozygous and homozygous Line 1 mice carrying the LRRK1 targeted (T) allele shows the presence of low levels of full-length LRRK1 mRNA in homozygous T/T mice, indicating that the targeted allele is not a null allele. Using an upstream cDNA probe specific for LRRK1 exons 2-3 (383 bp), the expected chimeric LRRK1-lacZ mRNA is the predominant LRRK1 transcript, in addition to small amounts of the full-length LRRK1 mRNA. The vertical lines in the middle of the blot images indicate where superfluous lanes were removed.
(C) Northern analysis of poly(A)+ RNA prepared from the kidney and brain of LRRK1 KO mice carrying the homozygous LRRK1-null allele (Line 2) using the downstream (exons 25-31) and upstream (exons 2-3) probes, respectively, shows the absence of the LRRK1 full-length mRNA in the kidney and brain of LRRK1 KO mice and the presence of the chimeric LRRK1-lacZ mRNA in LRRK1 KO brains, which can be revealed by the exons 2-3 probe but not the exons 25-31 probe. The value in the column indicates the number of mice used in each experiment. All data are expressed as mean ± SEM *p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S1 and Table S1. by two FRT sites, and the hbactP-neo cassette is flanked by two loxP sites. The introduction of the gene-trap En2SA-IRES-lacZ cassette was intended to cause gene inactivation by premature transcriptional termination, as splicing is expected to occur from the splice donor site of LRRK1 exon 3 to the splice acceptor site of exon 2 of the engrailed 2 gene (En2SA), leading to the predicted production of a chimeric transcript (LRRK1-lacZ) composed of LRRK1 exons 1-3, En2 exon 2, IRES, and lacZ sequences ( Figure S1A ). We confirmed the ESC clone carrying the targeted allele by Southern blotting using the 5 0 and 3 0 external probes ( Figure S1B ) as well as the neo probe (data not shown). The chimeric mice resulting from the confirmed ESCs were bred to B6/129 F1 mice to generate targeted LRRK1 mice, which were termed Line 1 (or ''Knockout First'' by KOMP). The germline transmission of the targeted LRRK1 allele was confirmed by Southern blotting using the 5 0 and 3 0 external probes (data not shown).
Northern analysis of RNA derived from the brain and kidney of mutant mice homozygous for the LRRK1 targeted allele (Line 1) revealed that there are small amounts of full-length LRRK1 mRNA using a cDNA probe specific for exons 25-31 ( Figure 1B ). qRT-PCR using primers specific for exons 30 and 31 confirmed that there are $19% and $13% of LRRK1 mRNA remaining in the brain and the kidney of these mutant mice, respectively (Figure S1C) . Using a cDNA probe specific for LRRK1 exons 2-3, we also detected the anticipated LRRK1-lacZ transcript in the brain and kidney of Line 1 targeted LRRK1 mutant mice ( Figure 1B ). RT-PCR using primers in exons 3 and 6 followed by sequencing identified not only normal LRRK1 transcripts (591 bp) retaining all exons examined (exons 3-6) but also an additional aberrant chimeric transcript (706 bp) containing LRRK1 exon 3, part of En2 exon 2, and LRRK1 exons 4-6 ( Figure S1D ), due to the presence of a putative splice donor site within En2 exon 2 (Figure S1A) . Therefore, the targeted allele (Line 1) is not a null allele as it allows expression of full-length LRRK1 mRNA as well as aberrant splice products ( Figures 1B and S1D) .
We then crossed Line 1 with Cre deleter mice and removed the floxed LRRK1 exons 4-5 to generate LRRK1 deletion mice (Line 2; Figure 1A ). Using the external 5 0 and 3 0 probes, Southern analysis confirmed the deletion of LRRK1 exons 4-5 in Line 2 mutant mice ( Figures S1F and 1A) . Northern analysis using cDNA probes specific for exons 25-31 or exons 2-3 revealed no detectable full-length LRRK1 mRNA in homozygous Line 2 deletion mice ( Figure 1C ). Extensive RT-PCR analysis followed by sequencing confirmed the absence of full-length LRRK1 mRNA in these homozygous Line 2 mice ( Figure S1G ). We therefore concluded that Line 2 represents a null allele and subsequently used this line for all phenotypic analysis. LRRK DKO (LRRK1 À/À ; LRRK2 À/À ) mice were obtained at the expected Mendelian ratio from intercrossing LRRK1 +/À ; LRRK2 +/À mice (Table S1 ). Western analysis confirmed the absence of LRRK1 and LRRK2 proteins in the lung of LRRK DKO mice, as LRRK1 is most abundant in the lung ( Figure 1D ).
LRRK DKO mice exhibit striking age-dependent reduction in body weight ( Figure 1E ), but the brain weight is largely unchanged ( Figure 1F ). The dramatic weight loss phenotype of LRRK DKO mice is absent in LRRK mutant mice carrying homozygous Line 1 and LRRK2-null alleles ( Figure S1E ), consistent with the presence of full-length LRRK1 mRNA in Line 1 mutants ( Figures 1B, S1C , and S1D). LRRK1 KO mice (Line 2) at 15 months also showed reduced body weight but normal brain weight (Figures S1I and S1J), and they did not exhibit earlier mortality. LRRK DKO mice die at $16 months of age with cataracts ( Figure S1H ). Figure 2B ), 8 months ( Figure S2G ), 10 months (data not shown), and 12 months ( Figure 2B ), but significantly reduced ($16%) at the age of 14 months ( Figure 2B Figures S2H-S2K ). We also measured the levels of striatal DA and its major metabolites using HPLC. The striatal DA level is significantly reduced in LRRK DKO mice at 15 months, compared to their wild-type littermate controls ( Figure 2E ), whereas DA levels are unchanged in LRRK DKO mice at 2 and 8 months ( Figure S2D ). Levels of dihydroxylphenylacetic acid (DOPAC), one of the major metabolites of DA, are also reduced in the striatum of LRRK DKO mice at 15 months ( Figure 2F ) but not at 2 and 8 months ( Figure S2E ). These results are consistent with the significant reduction of TH + DA neurons in the SNpc of LRRK DKO mice at 14-15 months. Because loss of noradrenergic neurons in the LC has also been reported in PD patients (Forno, 1996) , we quantified the number of TH + noradrenergic neurons in the LC. The number of noradrenergic neurons in the LC is significantly reduced in LRRK DKO mice at 15 months, relative to littermate wild-type controls ( Figures 2C and 2D) . Thus, LRRK function is required for survival of DA neurons in the SNpc and noradrenergic neurons in the LC.
Age
Age-Dependent, Selective Increases of Apoptosis in the LRRK DKO Brain To determine further whether loss of DA neurons and noradrenergic neurons in LRRK DKO mice is due to increases in apoptosis, we used an antibody specific for active caspases-3 and the TUNEL assay to label apoptotic cells. We observed increases of active caspases-3 + cells in the SNpc and striatum but not in the neocortex in LRRK DKO mice at 15 months (Figures 3A and 3B ). Figures S3C and S3D ), we did not observe increases in apoptosis in any of the brain sub-regions of LRRK DKO mice, relative to other genotypic groups. The age-dependent and selective increase of apoptotic cell death is consistent with the age-dependent loss of DA neurons in the SNpc of LRRK DKO mice. The increase in apoptosis in the striatum of LRRK DKO mice at 15 months prompted us to examine whether the number of medium spiny neurons, which represent >90% of neurons in the striatum and express the highest level of LRRK2 in the brain, is affected in the absence of LRRK. We used DARPP32 immunoreactivity to label medium spiny neurons and found that the number of medium spiny neurons and the volume of the striatum are indeed significantly reduced in LRRK2 DKO mice at this age (Figures 3E and 3F) .
Normal Cerebral Cortex and Cerebellum in LRRK DKO Mice To determine whether loss of LRRK function causes neurodegeneration in other brain sub-regions, we examined the cerebral cortex and the cerebellum. We used stereological methods to quantify the volume and neuron number in the cerebral cortex of LRRK DKO mice and wild-type littermate controls at 15 months of age and found that the volume of the cerebral cortex ( Figures 4A and 4B ) and the number of cortical neurons labeled by NeuN immunoreactivity ( Figures 4C and 4D ) are unchanged in LRRK DKO mice at 15 months. Further quantitative analysis of the cerebellum also showed normal cerebellar volume and number of Purkinje cells labeled by calbindin immunoreactivity in LRRK DKO mice at 15 months ( Figures  4E-4G ). Consistent with selective increases of apoptosis in brain (E and F) Reduced levels of striatal DA (E) and its metabolite DOPAC (F) measured by HPLC in LRRK DKO mice at 15 months, relative to wild-type littermate controls. The value in the column indicates the number of mice used in each experiment. All data are expressed as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001. Scale bar, 100 mm. See also Figure S2 .
sub-regions, these results further support the notion that loss of LRRK causes neurodegeneration in a neuron-subtype-specific manner.
Age-Dependent Increases of a-Synuclein in LRRK DKO Brains
We previously reported 60-fold increases of a-synuclein monomer in the LRRK2 À/À kidney at 20 months , but levels of a-synuclein are unchanged in LRRK2 À/À kidneys at 15 months (E.G. and J.S., unpublished data). We performed immunohistochemical and western analyses as well as ELISA to evaluate a-synuclein levels in the brain of LRRK DKO and control mice. Quantification of a-synuclein immunoreactivity indicated significant increases of a-synuclein in the SNpc and striatum but not in the neocortex of LRRK DKO mice at 15 months, relative to littermate wild-type controls ( Figures 5A and 5B), though a-synuclein immunoreactivity is unchanged in the SNpc and striatum of LRRK1 and LRRK2 single-KO mice ( Figures S4A and S4B ). Western analysis showed significant increases of a-synuclein monomer and higher-molecular-weight (HMW) species in the striatum of LRRK DKO mice ( Figures 5C and 5D ). ELISA also showed that a-synuclein levels are increased in the striatum but not in the neocortex of LRRK DKO mice at 15 months of age ( Figure 5E ). At 12 and 14 months of age, however, levels of a-synuclein immunoreactivity are not significantly changed in the SNpc, striatum, and neocortex of LRRK DKO mice ( Figures S4C-S4F ). These results indicate that loss of LRRK results in an age-dependent accumulation of a-synuclein in the SNpc and the striatum. We further examined whether ubiquitin-mediated protein degradation is affected in the brain of LRRK DKO mice. Immunohistochemical analysis revealed significant increases of ubiquitin immunoreactivity in the striatum of LRRK DKO mice at 15 months (Figures S4G and S4H) . Consistent with this finding, western analysis showed significant increases of HMW species immunoreactive for ubiquitin-specific antibodies in the striatum of LRRK DKO mice at 15 months (Figures S4I and S4J) but not at 12 months (data not shown), suggesting an age-dependent accumulation of ubiquitinated proteins in the absence of LRRK.
Age-Dependent Autophagy Impairment in LRRK DKO Brains To determine whether the autophagy-lysosomal pathway is affected in LRRK DKO brains during aging we evaluated p62, an autophagy substrate that binds to ubiquitin and forms complexes with LC3 (Bjørkøy et al., 2005; Ichimura et al., 2008) . We found significant increases of p62 immunoreactivity in different brain sub-regions, including the SNpc, striatum, neocortex, and optic tract in LRRK DKO mice at 15 months (Figures 6A and 6B) . Western analysis also showed significant increases of p62 in the dissected striatum, neocortex, and optic nerve of LRRK DKO mice at 15 months ( Figures 6C-6E ). We did not detect significant alterations in p62 immunoreactivity in the SNpc and striatum of LRRK1 and LRRK2 single-KO at 15 months of age ( Figures S5A and S5B ). Immunohistochemical analysis also showed co-localization of p62 and ubiquitin immunoreactivity in the optic tract of LRRK DKO mice at 15 months ( Figure 6G ). We further examined conversion of LC3-I, a homolog of Atg8 (Kabeya et al., 2000; Kirisako et al., 1999) , to the lipidated form, LC3-II, which is essential for the formation of autophagosomes and is a marker of autophagosome formation and accumulation (Mizushima et al., 2010 lipofuscin granules, leading to impaired protein/lipid degradation and autophagy function in aging neurons in the SNpc.
DISCUSSION
Mutations in LRRK2 are collectively the most common genetic cause of PD, associated with both familial and sporadic cases (Nalls et al., 2014; Paisá n-Ruíz et al., 2004; Satake et al., 2009; Simó n-Sá nchez et al., 2009; Zimprich et al., 2004) , highlighting the importance of LRRK2 in PD pathogenesis (Cookson, 2015; Pan and Yue, 2014; Tsika and Moore, 2012) . Genetic analysis revealed striking age-dependent autophagy impairment and accumulation of a-synuclein as well as increases of apoptosis in the LRRK2 À/À kidney (Tong et al., , 2012 . However, there is no loss of DA neurons reported in the LRRK2 À/À brain (Hinkle et al., 2012; Tong et al., 2010) , raising the possibility that LRRK1 may compensate for the loss of LRRK2 in the brain. Indeed, complete inactivation of LRRK1 and LRRK2 results in age-dependent loss of DA neurons in the SNpc and noradrenergic neurons in the LC as well as reduced levels of striatal DA and its metabolites (Figures 1 and 2) . Furthermore, age-dependent neurodegeneration is selective in the SNpc, LC and striatum of LRRK DKO mice, whereas the cerebral cortex and cerebellum are unaffected (Figure 4) . The selective neuronal loss in the SNpc and striatum is accompanied by increases of apoptosis (Figure 3) , enhanced a-synuclein levels ( Figure 5 ), and impaired autophagy ( Figure 6 ). Quantitative EM analysis further showed age-dependent accumulation of autophagic vacuoles in the SNpc of LRRK DKO mice (Figure 7) , before the onset of DA neuron loss and increases in apoptosis in the SNpc. Together, these findings demonstrate that LRRK plays a critical role in the regulation of the autophagy-lysosomal pathway and survival of DA neurons in the aging brain.
Essential Role of LRRK in DA Neuronal Survival
The motor symptoms associated with PD are caused by loss of DA neurons in the SNpc. Our genetic analysis revealed an essential role of LRRK in support of DA neuron survival during aging, as indicated by the normal number of DA neurons in the SNpc of LRRK DKO mice at 2, 8, 10, and 12 months of age, and agedependent, progressive reduction of DA neurons at 14 and 15 months (Figures 2 and S2 ). The loss of DA neurons is associated with age-dependent increases of apoptotic cell death in the SNpc of LRRK DKO mice, as shown by significant increases of active caspase-3 + and TUNEL + cells in the SNpc of LRRK DKO mice at 15 months but not at 12 months (Figures 3 and S3) . Age-dependent neurodegeneration is selective, as the cerebral cortex and the cerebellum of LRRK DKO mice at 15 months are not affected (Figure 4 ), but neurodegeneration is not restricted to DA neurons. We also observed significant reduction of noradrenergic neurons in the LC of LRRK DKO mice at 15 months (Figure 2 ), which are also vulnerable in PD, and increases of caspase-3 + apoptotic cells (data not shown). Furthermore, the volume of the striatum and the number of medium spiny neurons, which represent >90% of neurons in the striatum and express highest levels of LRRK2 in the brain, are also reduced in LRRK DKO mice at 15 months, accompanied with significant increases of apoptotic cells in the striatum (Figures 3 and S3) . Thus, DA neurons in the SNpc, along with noradrenergic neurons in the LC and GABAergic medium spiny The value in the column indicates the number of mice used in each experiment. All data are expressed as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001. Scale bars, 100 mm. See also Figure S4 .
neurons in the striatum, are more vulnerable to the loss of LRRK function during aging. The lethality of LRRK DKO mice at $16 months of age precluded further examination of older mice to determine the full impact of aging on the brain in the absence of LRRK. The cause of the earlier lethality in LRRK DKO mice is unclear, though metabolic analysis of these mice showed age-dependent decreases of food intake and fat content (E.G., L.K.W., and J.S., unpublished data). While LRRK DKO mice show marked agedependent reduction of body weight, their brain weight is largely unaffected (Figure 1) . Furthermore, the body weight is similarly reduced in LRRK1 KO and LRRK DKO mice at 15 months (Figure S1 ), but the loss of DA neurons in the SNpc is only present in LRRK DKO mice but not in LRRK1 KO or LRRK2 KO mice (Figure S2) . Therefore, selective, age-dependent neurodegeneration in LRRK DKO mice is unlikely caused by the gross abnormalities observed in these mice. However, development of DA neuronspecific LRRK conditional KO mice will address this question unequivocally and will determine the full extent of aging and loss of LRRK function in DA neuron survival. Furthermore, selective inactivation of LRRK in GABAergic medium spiny neurons in the striatum will determine whether loss of these neurons in LRRK DKO mice is cell autonomous. 
Regulation of the AutophagyLysosomal Pathway by LRRK
The mechanism underlying selective, age-dependent neurodegeneration and accompanying increases of apoptosis in LRRK DKO brains is not yet clear. Inhibition of autophagy has previously been reported to induce apoptotic neuronal death (Hara et al., 2006; Komatsu et al., 2006) , and conditional inactivation of Atg7 results in age-dependent neurodegeneration (Komatsu et al., 2007) . Interestingly, we observed significant increases of the autophagy substrate p62 in the SNpc of LRRK DKO brains at 15 months but not at 12 months ( Figures  6 and S5) , suggesting that the autophagy impairment may underlie the apoptotic cell death in the SNpc of LRRK DKO brains. Furthermore, quantitative EM analysis showed that the number of electron dense autophagic vacuoles is markedly increased in the SNpc of LRRK DKO mice at 10 months and further increased at 15 months (Figure 7) . The age-dependent accumulation of autophagic vacuoles in the SNpc of LRRK DKO mice is consistent with defects in autophagic flux reported in LRRK1 À/À mouse embryonic fibroblasts (Toyofuku et al., 2015) . The detailed mechanism by which LRRK regulates the autophagy-lysosomal pathway, however, is not yet clear and awaits further investigation. While the age-dependent autophagy impairment and DA neurodegeneration observed in LRRK DKO brains are correlative not causative, the fact that the accumulation of autophagic vacuoles precedes the onset of DA neurodegeneration in LRRK DKO brains suggests that the autophagy impairment may contribute to the increase in apoptosis and neurodegeneration in LRRK DKO brains. Similarly, as we observed in LRRK2 À/À kidneys (Tong et al., , 2012 , levels of a-synuclein are higher in the SNpc and striatum of LRRK DKO mice at 15 months of age ( Figure 5 ), further confirming the close link between LRRK2 and a-synuclein, which was reported by other groups as well (Lin et al., 2009; Skibinski et al., 2014) . However, while a-synuclein accumulation is striking in LRRK2 À/À kidneys at 20 months , increases of a-synuclein levels are much smaller in the SNpc and striatum of LRRK DKO brains. This is likely due to the age dependency of a-synuclein accumulation and the earlier lethality of LRRK DKO mice, which precludes analysis of these mice at older ages. For example, levels of a-synuclein are normal in LRRK2 À/À kidneys at 15 months (E.G. and J.S. unpublished data) but are $60-fold higher than control mice at 20 months, highlighting the effect of aging on a-synuclein accumulation in the absence of LRRK2. The findings that significant increases of a-synuclein in LRRK DKO brains were only observed at 15 months but not at 12 or 14 months (Figures 5 and S4), when autophagy impairment was already present, suggest that a-synuclein accumulation is the consequence of autophagy impairment. However, overexpression of a-synuclein in transgenic mice results in age-dependent neurodegeneration (Chandra et al., 2005; Giasson et al., 2002; Lee et al., 2002; Lin et al., 2009) . It is therefore possible that a-synuclein accumulation may further contribute to neuronal death during aging. It will be interesting to determine the full impact of aging on a-synuclein accumulation in DA neurons of LRRK conditional KO mice and whether introduction of a-synuclein transgenes will further exacerbate DA neurodegeneration in these mice.
Molecular Mechanisms Underlying LRRK Function
Despite our findings demonstrating the regulatory role of LRRK in autophagy and neuronal survival in vivo, the underlying molecular mechanism is unclear. Because LRRK2 contains a kinase domain, major efforts have been focused on the identification of its kinase substrates. Using two independent phosphoproteomic screens, Rab10 (pT73) and LRRK2 (pS935) were identified recently as substrates of LRRK2 0 s kinase activity, and subsequent analysis yielded Rab8a (pT72), Rab3a (pT86), and Rab12 (pS106) as additional substrates (Steger et al., 2016) . Furthermore, autophosphorylation of LRRK2 at Ser1292 has also been reported (Sheng et al., 2012) . The lack of phospho-specific antibodies, however, makes it difficult to evaluate whether the phospho-protein levels are altered in the absence of LRRK. While the physiological significance of these phosphorylation events and how these Rab proteins may be involved in mediating LRRK2 physiological function are unclear, several genome-wide association studies (GWAS) revealed that the PARK16 locus, which contains 5 transcription units including RAB7L1, is associated with sporadic PD (Satake et al., 2009; Simó n-Sá nchez et al., 2009; Tucci et al., 2010) . These association studies suggest that LRRK2 and Rab GTPases may interact in the pathogenesis of PD. Interestingly, Rab7L1-deficient mice share similar kidney phenotypes and lysosomal defects as LRRK2 À/À mice, providing further support for a functional connection between LRRK2 and Rab proteins (Kuwahara et al., 2016) . Future studies will be needed to elucidate how LRRK2 interacts with RAB7L1 and other Rab proteins in the regulation of the autophagy-lysosomal pathways. It will also be interesting to determine whether kinase activity is essential for the LRRK-mediated in vivo functions.
In summary, our current study revealed the essential role of LRRK in the regulation of the autophagy-lysosomal pathway and survival of selective neuronal populations in the aging brain. Loss of LRRK function in the mouse brain recapitulates several key features of PD, including age-dependent loss of DA neurons in the SNpc and noradrenergic neurons in the LC, impairment of the protein degradation pathways, a-synuclein accumulation, and increases of apoptosis. The earlier lethality of LRRK DKO mice, however, precluded further analysis of older mice to reveal the full impact of aging on DA neuron survival in the absence of LRRK. Conditional KO mice restricting LRRK inactivation to DA neurons only would be necessary to uncover the cell-autonomous consequences of loss of LRRK function on DA neurons, and future studies will be needed to elucidate the molecular mechanism by which LRRK regulates the autophagy-lysosomal pathway and protects DA neurons during aging.
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; LRRK2 +/À mice together. Most of the data from mice at 2, 8 and 15 months of age were obtained from analysis of LRRK DKO and wild-type mice, which were either littermates or from the same breeding pairs. Because of the low ratio (1/16) to obtain LRRK DKO and littermate wild-type mice, we subsequently used breeding pairs of LRRK DKO (or wild-type) mice crossing with each other to obtain more LRRK DKO (or wild-type mice). In this instance, the LRRK DKO and wild-type mice used in breeding were littermates or different litters from the same parents, so the resulting LRRK DKO and wild-type mice were only one generation apart in terms of their genetic background.
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METHOD DETAILS
Generation of LRRK1
-/-and LRRK -/-mice
To generate LRRK1 À/À mice, we purchased the ES cell clone carrying the LRRK1 ''knockout-first'' allele (EPD0073_6_C01) from the KOMP Repository (https://www.komp.org/) funded by the trans-NIH Knock-Out Mouse Project. The targeting vector contains a 5 0 homologous arm (4.6 kb of LRRK1 introns 3), the gene-trapping and selection cassettes and a 3 0 homologous arm (6.8 kb encompassing exons 4, 5, and 6). The entire En2SA-IRES-lacZ and hbactP-neo sequence is flanked by two FRT sites, and the hbactP-neo cassette is flanked by two loxP sites. The En2SA-IRES-lacZ trapping cassette includes the mouse En2 splice acceptor (En2SA), which contains intron 2 and exon 2 of the engrailed gene, the internal ribosome entry site (IRES) sequence, and the lacZ gene. The floxed neo cassette contains the human b-actin promoter, the neo cDNA and the SV40 polyadenylation sequence. A third loxP site was introduced into LRRK1 intron 5, allowing for removal of exons 4-5 in the presence of Cre recombinase. The targeting vector was introduced into ES cells derived from B6 mice.
We expanded the ES cells and verified the correct homologous recombination events by Southern blotting. Genomic ES DNA was digested with EcoRV or NheI, and the 5 0 and 3 0 external probes were used to confirm proper recombination in the 5 0 and 3 0 homologous regions, respectively. The PCR primer sequences for the 5 0 external probe (584 bp) are 5 0 -GACTTCCGAAGC CTGTTTGTCAG-3 0 and 5 0 -CTACCTTCTCCTGTGAGGATTCGCT-3 0 , and the primer sequences for the 3 0 external probe (867 bp) are 5 0 -GGTCATGATGGTCTATCACAGCAATAGT-3 0 and 5 0 -GATGCACTCACAGTCTTCGTGACTC-3 0 . We also confirmed that there is no random insertion of the targeting vector in the genome by Southern analysis using a neo cDNA probe. ES cells from the confirmed clone were injected into BALB/c blastocysts to generate chimeric mice. Mice carrying the targeted allele were bred to B6/129 F1 mice to generate heterozygous LRRK1 mice. The germline transmission of the targeted LRRK1 allele was confirmed using PCR and Southern blotting.
LRRK1 targeted mice (Line 1) were bred with aCaMKII-Cre transgenic mice to remove the floxed neo cassette and LRRK1 exons 4-5, because aCaMKII is expressed in male gametes (Ackermann et al., 2009 ). The resulting heterozygous mice (Line 2) were confirmed by Southern blotting for correct Cre-mediated recombination and proper removal of the neo cassette and LRRK1 exons 4-5, and by Northern and Western analyses for the absence of LRRK1 mRNA and protein. To generate LRRK DKO mice, LRRK1 À/À mice were crossed with our homozygous LRRK2 KO1 mice described previously to obtain LRRK1 +/À ; LRRK2 +/À mice, which were further intercrossed to generate LRRK DKO mice and controls for further phenotypic analysis.
Northern analysis
Total RNA was isolated from brains or kidneys using TRIzolÒ (Sigma), and polyA+ RNA were enriched using the MicroPoly(A)Purist kit (Ambion). Probes were synthesized using Prime-It II random labeling kit (Stratagene) and then used for membrane hybridization at 50 C overnight. The PCR primer sequences used to amplify cDNA probes are as follows: 5 0 -GCAGTGGCACAGTCATCTACCA-3 0 and 5 0 -GGCACATACCCTTAAGGCTGTAGA-3 0 for the probe specific for LRRK1 exons 25-31, 5 0 -CAGGATGAGCGTGTGTCTGCAG-3 0 and 5 0 -CCTTCTCCTGTGAGGATTCGCTCT-3 0 for the probe specific for LRRK1 exons 2-3. NIH ImageJ software was used to quantify the level of transcripts by comparing the intensities of the bands after subtracting the background.
RT-PCR
To perform real-time quantitative RT-PCR, total RNA isolated from brains and kidneys was used to synthesize cDNA (Superscript II from Invitrogen). Real-time PCR was performed in triplicate on a 96 well plate using an ABI 7900 detection system to assess the relative level of murine LRRK1 mRNA using a probe spans exons 30 and 31 (Mm00713303_m1, Applied Biosystems). Murine TBP (Mm00446973_m1) was used as the endogenous reference gene. Data plotted as mean ± SEM. For non-quantitative RT-PCR, the sequences of the primers used in RT and PCR are as follows 5 0 -CGAAGACATGGGCAGCAAACTG-3 0 for LRRK1 exon 3 and 5 0 -GGCTCAGGACTATCCAGCAGGATGTAG-3 0 for LRRK1 exon 6. The identity of the PCR product was confirmed by sequencing.
Western analysis
The striatum, neocortex, and optical nerve were dissected from the brain, and they were harvested from LRRK DKO mice and controls. Fresh tissues were homogenized in an ice-cold stringent RIPA buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.1% SDS, 1% Triton X-100, 1% sodium deoxycholate, supplemented with protease inhibitor mixture and phosphatase inhibitor mixtures; from Sigma), followed by sonication. Homogenates were centrifuged at 14,000 3 g for 20 min at 4 C to separate supernatants (RIPA buffer-soluble fractions). Equal amounts of total proteins from each preparation were loaded and separated on NuPAGE gels (Invitrogen) and transferred to nitrocellulose membranes. After blocking membranes were incubated at 4 C overnight with primary antibodies. Primary antibodies used were rabbit anti-LRRK1 (1:250; Thermo scientific), rabbit anti-LRRK2 (1:1000; made in-house), mouse anti-spectrin (1:10000; Sigma), rabbit anti-a-synuclein (1:1000; Santa Cruz), rabbit anti-ubiquitin (1:1000; Abcam), guinea pig anti-p62 (1:1000; Progen), rabbit anti-LC3 (1:1000; Sigma), mouse anti-b-actin (1:10000; Cell Signaling), and mouse anti-b-tublin (1:1000; Sigma). Membranes were then incubated with dye-coupled secondary antibodies (goat anti-rabbit IRdye680, goat antimouse IRdye680, donkey anti-guinea pig IRdye680, goat anti-rabbit IRdye800, goat anti-rat IRdye800, goat anti-mouse IRdye800 and donkey anti-guinea pig IRdye800 from LI-COR Bioscience). Signals were quantified using the Odyssey Infrared Imaging System (LI-COR Bioscience).
Histological analysis
Mice were anesthetized and then transcardially perfused with Ringer's solution containing 0.25 g/L heparin (Sigma) and 5 g/L procaine (Sigma) followed by ice-cold 4% formaldehyde in phosphate buffered saline (pH 7.4) (Electron Microscopy Sciences). Brains were post-fixed in 4% formaldehyde at 4 C overnight and then processed for paraffin embedding following standard procedures. Coronal brain sections were cut at 16 mm thickness, and sagittal sections were cut at 10 mm.
Immunohistochemical analysis
Coronal sections containing the SNpc or LC or neocortex and striatum and optic tract were selected, deparaffinized, rehydrated. All brain sections, except those for TH immunostaining, were subjected to permeabilization with a solution containing 0.1% Triton X-100, 0.1% sodium citrate in PBS and antigen retrieval by microwaving for 10 min in 10 mM sodium citrate buffer, pH 6.0. Endogenous peroxidase activity was quenched by incubating in 0.3% H 2 O 2 in methanol. Sections were then blocked with a solution containing 5% normal goat serum for 1 hr at room temperature (Vector Laboratories). After blocking, sections were incubated with primary antibodies overnight at 4 C. Primary antibodies were rabbit anti-TH (1:1000; Chemicon), rabbit anti-cleaved caspases-3 (1:150, Cell Signaling Technology), rabbit anti-a-synuclein (1:500; Santa Cruz), rabbit anti-ubiquitin (1:250; Abcam), or guinea-pig anti-p62 (1:200, Progen), followed by 1 hr incubation with biotinylated secondary antibodies and 1 hr incubation with Vectastain Elite ABC reagent and then developed using chromogenic DAB substrate (Vector Laboratories) as previously described (Yamaguchi and Shen, 2013) . For negative controls, primary antibodies alone or together with secondary antibodies were omitted from the incubation buffer. The number of apoptotic cells labeled by active caspase-3 antibodies was quantified using 3-6 coronal sections (5-10 sections apart), and the average number of apoptotic cells in the SNpc, striatum or neocortex per brain section was shown in the figure. The immunoreactivity of a-synuclein, ubiquitin or p62 was quantified using 2-6 coronal sections (10 sections apart), and the average immunoreactivity in the SNpc, striatum or neocortex per brain section was shown in the figure.
For NeuN and TH double immunostaining, coronal sections were deparaffinized, rehydrated, followed by quenching of the endogenous peroxidase activity using 0.3% H 2 O 2 in methanol. Sections were then blocked with a solution containing 5% normal goat serum for 1 hr at room temperature. After blocking, sections were incubated with mouse anti-NeuN (1:300; Milipore) antibody overnight at 4 C, followed by 1 hr incubation with biotinylated mouse secondary antibodies and 1 hr incubation with Vectastain Elite ABC reagent and then developed using chromogenic DAB substrate (brown color). Following several washes using 1x PBS, sections were then incubated with rabbit anti-TH antibody (1:1000; Chemicon) overnight at 4 C, followed by 1 hr incubation with biotinylated rabbit secondary antibodies and 1 hr incubation with Vectastain Elite ABC reagent and then developed using chromogenic DAB substrate containing Nickel (gray color) (Vector Laboratories).
Stereological neuron count
For stereological neuron count of DA and noradrenergic neurons, coronal sections were immunostained with TH antibody (1:1000; Chemicon). For LRRK DKO, LRRK1 KO, LRRK2 KO and wild-type mice at the ages of 12, 14 and 15 months, every 5 th coronal sections were used, whereas every 10 th coronal sections were used for mice at 2, 8 and 10 months. The number of DA neurons in the SNpc or noradrenergic neurons in the LC was determined using the fractionator and optical dissector method and was calculated to reflect both hemispheres. For the neocortex, every 40 th sagittal sections were stained with 0.5% cresyl violet (Nissl) or immunostained with mouse anti-NeuN (1:300; Milipore) antibodies. The cortical volume (Nissl) was quantified and was calculated to reflect both hemispheres, and the number of cortical neurons (NeuN+) was quantified. For the striatum, every 40 th sagittal sections were immunostained with mouse anti-DARPP-32 (1:200; Thermo scientific) antibodies, and the number of DARPP-32+ cells and the volume of the striatum were quantified. For the cerebellum, every 10 th sagittal sections were immunostained with the mouse anti-calbindin-D-28K (1:500; Sigma) antibody, and the cerebellar volume and the Purkinje cell number were quantified. The stereological neuron or volume quantification was done using the fractionator and optical dissector methods under an Olympus BX51 light microscope equipped with a CCD camera connected to a computer running Bioquant image analysis software. Images were captured using Olympus BX40 Dual Viewing Microscope.
TUNEL
Brain sections containing the SNpc or neocortex (coronal, 7 sections apart) or the striatum (sagittal, 40 sections apart) were chosen for the analysis. Deparaffinized and rehydrated brain sections were subjected to permeabilization with a solution containing 0.1% Triton X-100, 0.1% sodium citrate in PBS for 8 min and then immersed in 10 mM citrate buffer (pH 6.0) and boiled in a microwave oven for antigen retrieval for 5 min. For TUNEL, slides were blocked in 5% of goat serum for 60 min followed by treatment with fluorescein (Roche) at 37 C for 1 hr. The slides were then washed in PBS three times. For TUNEL and TH or DARPP-32 or NeuN colabeling, sections were incubated with primary antibodies overnight at 4 C; primary antibodies were TH, DARPP-32 (1:200; Thermo scientific) or NeuN, followed by 1 hr incubation with appropriate Alexa Fluor 488-conjugated secondary antibodies (Molecular Probes). Images were captured sequentially for TUNEL fluorescence (excitation: 559 nm, emission range: 575-675 nm) and TH, DARPP-32 or NeuN (excitation: 473 nm, emission range: 490-540 nm) using an Olympus FluoView FV1000 confocal microscope. The quantification of the fluorescence was analyzed using the ImageJ software. The number of apoptotic cells labeled by TUNEL was quantified using 2 sections, and the average number of apoptotic cells in the SNpc, striatum or neocortex per brain section was shown in the figure.
Measurements of striatal DA and its metabolites by HPLC The striatum was dissected, weighed, and stored at À80 C until use. Frozen striata were sonicated in ice-cold solution (0.1 M perchloric acid/0.2 mM sodium bisulfite) and centrifuged for 10 min at 14,000 3 g at 4 C. The supernatant was filtered and applied to C18 reverse phase HPLC columns connected to an Alexys LC-100 system (Antec-Leyden, Hanover, MD, USA) with electrochemical detection (DECADE II) and a VT-03 electrochemical flow cell. DA measurements were made using a detection potential of 320 mV and isocratic elution (50 mM phosphoric acid, 500 mg/L octane sulfonic acid, 0.1 mM EDTA, 8 mM KCl, pH 6.0, and 10% methanol; from Sigma) through a 50 3 2.1 mm HPLC column at the flow rate of 0.2 mL/min. DA metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) eluted isocratically on a 150 3 2.1 mm HPLC column at lower pH (50 mM phosphoric acid, 50 mM citric acid, 400 mg/L octane sulphonic acid, 0.1 mM EDTA, 8 mM KCl, pH 3.75, and 3% methanol) at the flow rate 0.2 mL/min and detected at 590 mV. Concentrations of DA, its metabolites, and DOPA in the striatal samples were obtained by comparing with a series of catecholamine standards of known concentrations, which were run under the same conditions. The levels of DA, its metabolites, and DOPA were normalized to tissue weight. ELISA Alpha-synuclein levels in the striatum and neocortex were assessed using Mouse synuclein, AlphaELISA Kit (Neo scientific) according to the manufacturer's protocol. Briefly, homogenates from the dissected striatum or neocortex were plated in duplicates and incubated in the presence of balance solution and enzyme solution in pre-blocked wells for 1 hr at 37 C. Substrates were added to each well and incubate at room temperature for 15 min after stop solution was added the optical density at 450 nm was measured.
Quantitative EM analysis
Mice were perfused with a fixative solution containing a mixture of 2.5% paraformaldehyde and 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.4) (Electron Microscopy Sciences, #1549, Hatfield, PA, USA). Brains were dissected and then placed on a vibratome to trim off the cerebellum and the anterior portion of the brain, and three coronal sections in 300 mm thickness spanning the SNpc region were post fixed overnight with the fixative solution at 4 C. One of the sections (300 mm) was used for TH immunostaining to confirm the presence of TH+ DA neurons in the SNpc. The adjacent section was used for EM analysis and left in the fixative until processing for embedding in resin. Embedding and ultrathin sectioning was done by the Harvard Medical School EM facility. In brief, the tissue was post fixed with 1% Osmium tetroxide (OsO4)/1.5% Potassium ferrocyanide (KFeCN6) for 1 hr, washed 2 times in water followed by 50mM Maleate buffer pH 5.15 (MB) and incubated in 1% uranyl acetate in MB for 1hr and dehydrated in ascending alcohols followed by incubation in propylene oxide. Tissue was incubated overnight in a 1:1 mixture of propylene oxide and TAAB Epon (Marivac Canada). The following day the samples were embedded in TAAB Epon and polymerized at 60 C for 48 hr. Ultrathin sections (about 80 nm) were cut on a Reichert Ultracut-S microtome, picked up on to copper grids stained with lead citrate and examined in a JEOL 1200EX Transmission electron microscope. Images were recorded with an AMT 2k CCD camera. For each brain area (Striatum and SNpc) a minimum of 10 micrographs containing an entire neuronal cell body were taken for each genotype and age, respectively.
A minimum of 10 micrographs containing the entire neuronal cell body was analyzed for each brain. The number of electron-dense autophagic and lysosomal vacuoles larger than 0.5 mm in diameter in each neuronal body was counted at a magnification of 2500-4000x. Higher magnification micrographs (10000-20000x) were taken to confirm the presence of autophagosomes and autolysosomes.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data acquisition and quantification was performed in a genotype blind manner with the exception of the molecular analysis (Southern, Northern, Western). All statistical analyses were performed using Prism 7 (GraphPad Software) or Excel (Microsoft). All data are presented as the means ± SEM. The exact sample size (e.g., the number of mice, brains or neurons) of each experiment is provided in the relevant figures.
Statistical analyses were conducted using t tests ( Figures 2B, 2D-2F , 3B, 3D, 3F, 4B, 4D, 4F, 4G, 5D, 5E, 6D, and 6F), one-way ANOVA followed up by Tukey's multiple comparisons tests ( Figures 1E, 5B , 6B, and 7K) or one-way ANOVA followed up by Newman-Keuls multiple comparison tests ( Figures 1F) . All statistical comparisons were performed on data from R 3 biologically independent samples and replicated on different experimental days. Significance is shown as *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, and not significant values are not noted.
